Author

Binbin Wang

National Institutes of Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 3 Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

Eytan RuppiniD· 2 shared Abbas Yousefi-Rad· 1 shared Alejandro A. SchäfferiD· 1 shared Allison L. HuntiD· 1 shared Amos StemmeriD· 1 shared Andrea Borghese ApoloiD· 1 shared Anish ThomasiD· 1 shared Anna-Lena MeinhardtiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Eytan RuppinORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Layer-Specific Source-Anchored Transfer Learning for Multi-Omics Survival Prediction in Younger Breast Cancer Patients

Wanru Guo, Binbin Wang, Curtis Tatsuoka

This paper introduces LSAT-EN, a transfer learning method that improves survival prediction for younger breast cancer patients using multi-omics data from older patients.

bioRxiv · Nov 4, 2026 · PreprintBioinformatics

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer

Brett Schroeder, Jae Choi, Alejandro A. Schäffer, Michael Nirula, Yingying Cao, Yang Zhang, Anna-Lena Meinhardt, Hyeokjun Kwon, Hyerim Park, Sangin Lee, Hyo Jin Shin, Hee Geon Park, Hobin Yang, Sungyoul Hong, Parth Desai, , Anish Thomas

The paper identifies CLDN3 as a tumor-selective target in SCLC using proteogenomic analysis and validates its therapeutic potential with a monoclonal antibody.

bioRxiv · Jul 30, 2026 · PreprintCancer Biology

Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology

Sumit Mukherjee, Sumeet Patiyal, Lipika R. Pal, Keluo Yao, Tiangen Chang, Sumona Biswas, Saugato Rahman Dhruba, Amos Stemmer, Arashdeep Singh, Abbas Yousefi-Rad, Tien-Hua Chen, Binbin Wang, Denis Marino, Wonwoo Shon, Yuan Yuan, , Eytan Ruppin

This paper introduces TIME_ACT, a transcriptomic signature predicting immune checkpoint blockade response across cancers, validated using histopathology and multiple cohorts.

bioRxiv · Jun 27, 2025 · PreprintCancer Biology